Latest1 information on COVID-19
Support teaching, research, and patient care.
Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies
Elizabeth Winters
650-721-6509
All fields are required. *
We were not able to send your contact info at this time.